Browse News
Filter News
Found 534,875 articles
-
BioSpace Movers and Shakers: Jan. 18
1/18/2019
Pharma and biotech companies make changes to their board and leadership teams to advance pipelines and strategies, at SQZ, AstraZeneca, Bioasis, and more. -
January 18 Research Roundup: Skin Cancer, Turning Cancer Cells Into Fat Cells, and a Longevity Test
1/18/2019
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them. -
The rate of incidence of infection by Naegleria fowleri in the U.S. is very, very low. But there’s something about picking up an incurable, brain-eating amoeba by swimming in freshwater lakes and rivers that understandably freaks people out.
-
Crafoord Prize Awarded for Discovery of Miniscule Organism
1/18/2019
This year's Crafoord Prize has been awarded to Sallie Chisholm for the discovery of and research into Prochlorococcus, a very small cyanobacteria of huge importance.
-
Ipsen: Patients Living with Spasticity Want Long-lasting Symptom Relief
1/18/2019
International survey presented at TOXINS 2019 reveals hidden burden of spasticity
-
Aratana Therapeutics' Board of Directors Appoints Craig Tooman Chief Executive Officer
1/18/2019
Aratana Therapeutics, Inc. announced the Company's Board of Directors has appointed Craig Tooman to serve as President and Chief Executive Officer of Aratana, and elected Tooman to the Board of Directors.
-
Hansa Medical Announces Appointment of Anne Säfström Lanner as Vice President, Global Human Resources
1/18/2019
Hansa Medical AB announced the appointment of Anne Säfström Lanner as Vice President, Global Human Resources.
-
The third time may be the charm for Framingham, Mass.-based Alzheon when it comes to an initial public offering – because the company has balked the first two times it attempted to go public on the stock exchange.
-
SQZ Biotech is on a roll. Months after securing $72 million in a Series C financing round and expanding a developmental agreement with pharma giant Roche worth up to $1 billion, the company is now expanding its footprint in Watertown, Mass.
-
Although that is good news, cancer is the second-most common cause of death in the U.S., with more than 1.7 million new cancer cases each year and more than 600,000 cancer deaths. The report notes that one of the biggest factors in decreased cancer rates are lower tobacco smoking rates.
-
This follows a 2017 rejection by the agency, requesting more data. As Jefferies analyst Michael Yee wrote in a note to clients, Amgen is “back in the game.”
-
U.S. federal lawmakers are discussing various legislative plans that could lower the out-of-pocket expenses many Americans pay for their medications. The plans are coming from both chambers of Congress and with a divided government, lines in the sand will likely be drawn.
-
The U.S. government has been pushing to increase access to experimental drugs over the last two years. On August 18, 2018, the RACE for Children Act was signed into law as part of the 2017 FDA Reauthorization Act, which amended the Pediatric Research Equity Act (PREA).
-
Brain plasticity refers to the brain’s ability to change throughout life. When young, the brain is highly plastic, but becomes less so as we age. Too much plasticity can be a problem, but it's necessary for the brain’s ability to repair itself or reorganize itself after injury or when learning ne...
-
A study published in Clinical Chemistry earlier this month has linked sperm with more DNA damage to repeated miscarriages. Recurring miscarriages, defined as three or more consecutive miscarriages before 20 weeks of pregnancy, occur in 1-2 percent of couples.
-
Acrotech Biopharma, a New Jersey-based subsidiary of Aurobindo Pharma USA, is buying Henderson, Nevada-based Spectrum Pharmaceuticals’ seven FDA-approved hematology/oncology products.
-
The researchers identified a group of centyrins that blocked the action of five toxins generated by Staphylococcus aureus, the bacteria that causes Staph infections.
-
Louisiana Mesothelioma Victims Center Now Urges a Person in Louisiana With Mesothelioma or Asbestos Exposure Lung Cancer to Call Them for Direct Access to Erik Karst, One of the Nation's Most Skilled Lawyers for Compensation
1/17/2019
The Louisiana Mesothelioma Victims Center says, "We are urging a person in Louisiana who has recently been diagnosed with mesothelioma or asbestos exposure lung cancer and or their family members to call us anytime at 800-714-0303 for direct access to Erik Karst, founding partner of the law firm Karst von Oiste.
-
MorphoSys Announces that its Licensee Janssen has Expanded Clinical Development of Guselkumab (Tremfya(R)) into Ulcerative Colitis
1/17/2019
MorphoSys AG announced that its licensee Janssen Research & Development, LLC (Janssen), has further expanded the clinical development of guselkumab (Tremfya(R)) into ulcerative colitis (UC).
-
US Navy Mesothelioma Center Now Urges a Family That Recently Lost Their Navy Veteran Loved One to Mesothelioma to Call Them First for Direct Access to Mesothelioma Attorney Erik Karst of Karst von Oiste for Better Compensation Results
1/17/2019
The US Navy Veterans Mesothelioma Center says, "If your US Navy Veteran husband or dad just died of confirmed mesothelioma before the financial compensation claim was able to begin, please call us as soon as possible at 800-714-0303 so we can try to help